Arrakis Therapeutics (United States)

Recent papers from Arrakis Therapeutics (United States)

1. Single Molecule Force Measurements Reveal Energy Stabilization of Theophylline Aptamer RNA Switch Required for Gene ControlACS Physical Chemistry Au · 2026
2. Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers2025
3. TTF2 promotes replisome eviction from stalled forks in mitosis2024
4. N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translationNature Communications · 2024
5. Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low TumorsBioMed Research International · 2024
6. Unstructured Domains in Assembly Factors Promote the Hierarchy of Ribosome Maturation via Their Structural Plasticity2023
7. Defining the condensate landscape of fusion oncoproteinsNature Communications · 2023
8. A disease associated mutant reveals how Ltv1 orchestrates RP assembly and rRNA folding of the small ribosomal subunit head2023
9. Discovery of small molecules that target a tertiary-structured RNAProceedings of the National Academy of Sciences · 2022
10. PEARL-seq: A Photoaffinity Platform for the Analysis of Small Molecule-RNA InteractionsACS Chemical Biology · 2020
11. Novel Nucleic Acid Binding Small Molecules Discovered Using DNA-Encoded ChemistryMolecules · 2019
12. Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cellsNature Communications · 2018
13. UDiTaS™, a genome editing detection method for indels and genome rearrangementsBMC Genomics · 2018